ProSomnus, Inc Common Stock

Price & Volume

Stats

52W Range	$0.004-$1.36
Market Cap	$8.1M
Shares Short	73,907

Financials

Revenue (12 Mos)	$27.6M
Revenue Growth (YoY)	35.3%
Gross Profit (12 Mos)	$7.3M
Diluted EPS	-$1.49

News

Yahoo Finance • 11 months ago

ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results

Yahoo Finance • last year

ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference

Yahoo Finance • last year

ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences

Yahoo Finance • last year

Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep Apnea

About

CEO	Mr. Leonard Liptak
CFO	Mr. Brian B. Dow
Address	5675 Gibraltar Drive, Pleasanton, CA, United States, 94588
Sector	Healthcare
Industry	Medical Devices
Full-Time Employees	136